Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
featured

Journal Scan / Case Study · November 25, 2016

Aromatase Inhibitors With or Without an LH-RH Agonist Is an Effective Option for HR+ Male Metastatic Breast Cancer

Breast Cancer (Tokyo, Japan)

 

Additional Info

Disclosure statements are available on the authors' profiles:

Breast Cancer (Tokyo, Japan)
Aromatase Inhibitors With or Without Luteinizing Hormone-Releasing Hormone Agonist for Metastatic Male Breast Cancer: A Report of Four Cases and Review of the Literature
Breast Cancer 2016 Nov 01;23(6)945-949, S Kuba, M Ishida, M Oikawa, Y Nakamura, K Yamanouchi, E Tokunaga, K Taguchi, T Esaki, S Eguchi, S Ohno

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading